Solid lipid nanoparticle (SLN) formulations as a potential tool for the reduction of cytotoxicity of saponins

Pharmazie

Volumn 64, Issue 3, 2009, Pages 172-176

  Van De Ven, H ^a   Vermeersch, M ^a   Shunmugaperumal, T ^a   Vandervoort, J ^a   Maes, L ^a   Ludwig, A ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; CATION; EDELFOSINE; ESCIN; RESAZURIN; SAPONIN; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; WITEPSOL; WITEPSOL H 12; WITEPSOL S 55; WITEPSOL W 45; NANOPARTICLE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DIPLOIDY; FETUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIGHT SCATTERING; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PILOT STUDY; QUILLAJA; ZETA POTENTIAL; ANIMAL; CARBOHYDRATE ANALYSIS; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; MOLECULAR GENETICS;

ANIMALS; CARBOHYDRATE SEQUENCE; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; ESCIN; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NANOPARTICLES; PARTICLE SIZE; SAPONINS;

EID: 65349147614     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.8222     Document Type: Article

References (32)

1. Bocca C, Caputo O, Cavalli R, Gabriel L, Miglietta A, Gasco MR (1998) Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nano-particles. Int J Pharm 175: 185-193.
2. Catelas I, Petit A, Zuko DJ, Marchand R, Yahia L, Huk OL (1999) Induction of macrophage apoptosis by ceramic and polyethylene particles in vitro. Biomaterials 20: 625-630.
3. Crouch SPM, Slater KJ (2001) High-throughput cytotoxicity screening: hit and miss. Drug Discov Today 6 (Suppl): 48-53.
4. Date AA, Joshi MD, Patravale VB (2007) Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 59: 505-521.
5. Estella-Hermoso de Mendoza A, Rayo M, Mollinedo F, Blanco-Prieto MJ (2008) Lipid nanoparticles for alkyl lysophospholipid edelfosine encapsulation: development and in vitro characterization. Eur J Pharm Biopharm 68: 207-213.
6. Germonprez N, Van Puyvelde L, Maes L, Van Tri M, De Kimpe N (2004) New pentacyclic triterpene saponins with strong anti-leishmanial activity from the leaves of Maesa balansae. Tetrahedron 60: 223-232.
7. Gupta S, Vyas SP (2007) Development and characterization of amphotericin B bearing emulsomes for the passive and active macrophage targeting. J Drug Target 15: 206-217.
8. Hartke K, Mutschler E (1986) Deutsches Arzneibuch 9-Kommentar, pp. 3008-3013.
9. Hostettmann K, Marston A (1995) Saponins. In: Phillipson JD, Ayres DC, Baxter H (ed.) Chemistry & pharmacology of natural products, Cambridge, pp. 239-284.
10. Lemarchand C, Gref R, Passirani C, Garcion E, Petri B, Müller R, Costantini D, Couvreur P (2006) Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials 27: 108-118.
11. Maes L, Vanden Berghe D, Germonprez N, Quirijnen L, Cos P, De Kimpe N, Van Puyvelde L (2004) In vitro and in vivo activity of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral Leishmania species. Antimicrob Agents Chemotherap 48: 130-136.
12. Martins de Lima T, de Sa Lima L, Scavone C, Curi R (2006) Fatty acid control of nitric oxide production by macrophages. FEBS Letters 580: 3287-3295.
13. McMillian MK, Li L, Parker JB, Patel L, Zhong Z, Gunnett JW, Powers WJ, Johnson MD (2002) An improved resazurin-based cytotoxicity assay for hepatic cells. Cell Biol & Toxicol 18: 157-173.
14. Mehnert W, Mäder K (2001) Solid lipid nanoparticles. Production, characterization and applications. Adv Drug Del Rev 47: 165-196.
15. Mosmann TR (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 65: 55-63.
16. Mullen AB, Carter KC, Baillie AJ (1997) Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis. Antimicrob Agents Chemother 41: 2089-2092.
17. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 50: 161-177.
18. Nakano K, Tozuka Y, Takeuchi H (2008) Effect of surface properties of liposomes coated with a modified polyvinyl alcohol (PVA-R) on the interaction with macrophage cells. Int J Pharm 354: 174-179.
19. O'Brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resaruzin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267: 5421-5426.
20. Olbrich C, Schöler N, Tabatt K, Kayser O, Müller RH (2004) Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production. J Pharm Pharmacol 56: 883-891.
21. Sapino S, Carlotti ME, Pelizzetti E, Vione D, Trotta M, Battaglia L (2005) Protective effect of SLNs encapsulation on the photodegradation and thermal degradation of retinyl palmitate introduced in hydroxyethylcellulose gel. J Drug Del Sci Tech 15: 159-165.
22. Schöler N, Olbrich C, Tabatt K, Müller RH, Hahn H, Liesenfeld O (2001) Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int J Pharm 221: 57-67.
23. Schöler N, Hahn H, Müller RH, Liesenfeld O (2002) Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages. Int J Pharm 231: 167-176.
24. Schrijvers DM, Martinet W, De Meyer GR, Andries L, Herman AG, Kockx MM (2004) Flow cytometric evaluation of a model for phagocytosis of cells undergoing apoptosis. J Immunol Methods 287: 101-108.
25. Torchillin VP (2007) Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPSJ 11 (9): E128-147.
26. Üner M (2006) Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie 61: 375-386.
27. van Setten DC, van de Werken G (1996) Molecular structures of saponins from Quillaja saponaria Molina. In: Waller GR, Yamasaki K (ed.) Advances in experimental medicine and biology, Vol. 404, New York, pp. 185-193.
28. Vyas SP, Khatri K (2007) Liposome-based drug delivery to alveolar macrophages. Expert Opin Drug Deliv 4: 95-99.
29. Watson P, Jones AT, Stephens DJ (2005) Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv Drug Deliv Rev 57: 43-61.
30. Wissing SA, Kayser O, Müller RH (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Del Rev 56: 1257-1272.
31. Yardley V, Croft SL (2000) A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis. Int J Antimicrob Agents 13: 243-248.
32. Yuan H, Miao J, Du Y, You J, Hu F, Zeng S (2008) Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm 348: 137-145.